Insider Trading & Ownership - Sun Elaine D

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Sun Elaine D

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-03-17
Option Award
2025-03-19
4:27 pm
N/A
2035-03-17
RECURSION PHARMACEUTICALS INC. RXRX Sun Elaine D
Director
109,648 $0 109,648
(Direct)
View
2024-05-23
Option Award
2024-05-28
8:19 pm
N/A
2031-05-22
DYNAVAX TECHNOLOGIES CORP DVAX Sun Elaine D
Director
27,857 $0 46,607
(Direct)
View
2023-05-26
Option Award
2023-05-31
5:34 pm
N/A
2030-05-25
DYNAVAX TECHNOLOGIES CORP DVAX Sun Elaine D
Director
27,857 $0 41,250
(Direct)
View
2022-05-26
Option Award
2022-05-27
5:01 pm
N/A
N/A
DYNAVAX TECHNOLOGIES CORP DVAX Sun Elaine D
Director
13,929 $0 13,929
(Direct)
View
2021-12-10
Option Award
2021-12-14
7:23 pm
N/A
N/A
DYNAVAX TECHNOLOGIES CORP DVAX Sun Elaine D
Director
55,714 $0 55,714
(Direct)
View

Ownership
2021-12-14
5:04 pm
N/A
N/A
DYNAVAX TECHNOLOGIES CORP DVAX Sun Elaine D
Director
0 $0 0
(Direct)
View
2021-04-01
Tax Withholding
2021-04-01
7:43 pm
N/A
N/A
HALOZYME THERAPEUTICS INC. HALO Sun Elaine D
SVP, Chief Financial Officer
4,059 $42.43 44,618
(Direct)
View
2021-04-01
Exercise
2021-04-01
7:43 pm
N/A
N/A
HALOZYME THERAPEUTICS INC. HALO Sun Elaine D
SVP, Chief Financial Officer
10,196 $0 44,618
(Direct)
View
2021-03-02
Exercise
2021-03-02
7:15 pm
N/A
N/A
HALOZYME THERAPEUTICS INC. HALO Sun Elaine D
SVP, Chief Financial Officer
12,166 $0 44,377
(Direct)
View
2021-03-02
Tax Withholding
2021-03-02
7:15 pm
N/A
N/A
HALOZYME THERAPEUTICS INC. HALO Sun Elaine D
SVP, Chief Financial Officer
4,285 $45.01 44,377
(Direct)
View
2021-02-15
Option Award
2021-02-17
5:03 pm
2022-02-15
2031-02-15
HALOZYME THERAPEUTICS INC. HALO Sun Elaine D
SVP, Chief Financial Officer
40,540 $0 40,540
(Direct)
View